Associate Professor Ruth Peters completed her PhD and NIHR Post-doctoral Fellowship at Imperial College London before relocating to Australia in 2018. Dr Peters’ research combines clinical trials, evidence synthesis, and epidemiology to understand and treat risk factors for dementia and frailty.  Her work has influenced WHO and national and international clinical practice guidelines, is used by health advocacy bodies and is regularly featured in the media, for example;  https://www.abc.net.au/news/2022-10-26/study-finds-evidence-lowering-blood-pressure-later-can-help/101578342.  

A/Prof Peters has been awarded >$10 million in research funding, is widely cited and is regularly invited to give talks at conferences and scientific meetings. She has a particular passion for the two areas that show the most potential for helping healthy brain ageing, multidomain risk reduction and the treatment of hypertension.

As part of her research program in multidomain risk reduction, A/Prof Peters is leading her team in delivering the first large multisite trial to test intergenerational practice, a novel multi-domain intervention bringing older adults and preschool children together combining physical activity, cognitive and social engagement to reduce cognitive decline and frailty and co-designed with community members.

In hypertension Dr Peters is currently leading an exciting new research stream at The George Institute for Global Health including innovative clinical trial and evidence synthesis projects in blood pressure lowering, dementia and frailty and has an established international reputation since her early PhD work as cognitive function lead for the award-winning multinational Hypertension in the Very Elderly Trial (HYVET, HYVET -COG).

Ruth Peters (0000-0003-0148-3617) - ORCID

Ruth Peters | The George Institute for Global Health